Successful treatment of prednisolone- and imatinib-refractory JAK2-V617F-Muation-postive myelodysplastic syndrome, accompanied by cerebral and cardiac manifestation of excessive eosinophilia, with AML-like chemotherapy followed by interferone-α maintenance

M Wiederseiner, P Eder, C Pfeiffer, C Stoll, G Hoppe, I Baumann, M Höher, Johannes Schwab, A Kiani

    Research output: Contribution to conferenceAbstract

    Original languageUndefined/Unknown
    Publication statusPublished - 2010

    Cite this